IT201700109607A1 - Composition for use in the prevention and / or treatment of glaucoma. - Google Patents

Composition for use in the prevention and / or treatment of glaucoma.

Info

Publication number
IT201700109607A1
IT201700109607A1 IT102017000109607A IT201700109607A IT201700109607A1 IT 201700109607 A1 IT201700109607 A1 IT 201700109607A1 IT 102017000109607 A IT102017000109607 A IT 102017000109607A IT 201700109607 A IT201700109607 A IT 201700109607A IT 201700109607 A1 IT201700109607 A1 IT 201700109607A1
Authority
IT
Italy
Prior art keywords
glaucoma
prevention
treatment
composition
Prior art date
Application number
IT102017000109607A
Other languages
Italian (it)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102017000109607A priority Critical patent/IT201700109607A1/en
Priority to PCT/IB2018/057531 priority patent/WO2019064245A1/en
Priority to EP18789222.9A priority patent/EP3687526A1/en
Publication of IT201700109607A1 publication Critical patent/IT201700109607A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT102017000109607A 2017-09-29 2017-09-29 Composition for use in the prevention and / or treatment of glaucoma. IT201700109607A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT102017000109607A IT201700109607A1 (en) 2017-09-29 2017-09-29 Composition for use in the prevention and / or treatment of glaucoma.
PCT/IB2018/057531 WO2019064245A1 (en) 2017-09-29 2018-09-28 A composition for use in the prevention and/or treatment of glaucoma
EP18789222.9A EP3687526A1 (en) 2017-09-29 2018-09-28 A composition for use in the prevention and/or treatment of glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000109607A IT201700109607A1 (en) 2017-09-29 2017-09-29 Composition for use in the prevention and / or treatment of glaucoma.

Publications (1)

Publication Number Publication Date
IT201700109607A1 true IT201700109607A1 (en) 2019-03-29

Family

ID=61024947

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000109607A IT201700109607A1 (en) 2017-09-29 2017-09-29 Composition for use in the prevention and / or treatment of glaucoma.

Country Status (3)

Country Link
EP (1) EP3687526A1 (en)
IT (1) IT201700109607A1 (en)
WO (1) WO2019064245A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200008894A1 (en) * 2022-05-03 2023-11-03 Biodue S P A Nutraceutical composition including citicoline, vitamin D3 and hemp oil.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007040798A1 (en) * 2007-08-28 2009-04-02 Innovative Naturalsinc Herb mixture, useful e.g. to slow the aging process, comprises e.g. Crocus sativus, Elettaria cardamomum, Cinnamomum zeylanicum, Hedychium spicatum, Terminalia chebula, Trichosanthes dioica, Coleus forskolin and Berberis aristata

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007040798A1 (en) * 2007-08-28 2009-04-02 Innovative Naturalsinc Herb mixture, useful e.g. to slow the aging process, comprises e.g. Crocus sativus, Elettaria cardamomum, Cinnamomum zeylanicum, Hedychium spicatum, Terminalia chebula, Trichosanthes dioica, Coleus forskolin and Berberis aristata

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MICHELE VETRUGNO ET AL: "Oral Administration of Forskolin and Rutin Contributes to Intraocular Pressure Control in Primary Open Angle Glaucoma Patients Under Maximum Tolerated Medical Therapy", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS., vol. 28, no. 5, 1 October 2012 (2012-10-01), US, pages 536 - 541, XP055221416, ISSN: 1080-7683, DOI: 10.1089/jop.2012.0021 *
MOHAMMAD HOSSEIN JABBARPOOR BONYADI ET AL: "The ocular hypotensive effect of saffron extract in primary open angle glaucoma: a pilot study", BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, BIOMED CENTRAL LTD., LONDON, GB, vol. 14, no. 1, 15 October 2014 (2014-10-15), pages 399, XP021201029, ISSN: 1472-6882, DOI: 10.1186/1472-6882-14-399 *
REJDAK ROBERT ET AL: "Oral citicoline treatment improves visual pathway function in glaucoma", MEDICAL SCIENCE MONITOR, MEDISCIENCE PUBLIKACJE NAUKOWE, WARZAW, PL, vol. 9, no. 3, 1 March 2003 (2003-03-01), pages PI24 - PI28, XP002319127, ISSN: 1234-1010 *

Also Published As

Publication number Publication date
EP3687526A1 (en) 2020-08-05
WO2019064245A1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
EP4272834A3 (en) Therapeutic use of mitochondria and combined mitochondrial agents
IL255203B (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of dermatological conditions or disorders
CO2021004456A2 (en) Multivalent pneumococcal vaccines
PL3759083T3 (en) 2,4-diaminoquinazoline derivatives and use thereof in the treatment of virus infections, cancer or allergies
MX2023014145A (en) Modified oligonucleotides and methods of use.
WO2015106215A3 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
IT201700025666A1 (en) Composition for use in the treatment of hypercholesterolemia and in the prevention of cardiovascular diseases.
EP3261446A4 (en) Methods and compositions for the treatment or prevention of parkinson's disease
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
IT201600081379A1 (en) Pharmaceutical composition for use in the treatment of prostatic diseases.
IT201700085412A1 (en) Composition for use in the prevention and treatment of cardiovascular diseases
IT201700089258A1 (en) Composition for use in the prevention and treatment of iron deficiency
IT201700121764A1 (en) Composition for the treatment and / or prevention of neurodegenerative diseases.
WO2014117010A3 (en) Composition for ophthalmic administration
CO2019014647A2 (en) Immunogenic compositions
IT201700109607A1 (en) Composition for use in the prevention and / or treatment of glaucoma.
EP3199163A4 (en) Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies
ES2660372T8 (en) Substances and procedures for use in the prevention and / or treatment of Huntington's disease
IT201600122310A1 (en) Composition for use in the treatment of bowel disorders
IL282142A (en) 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
IT201700090582A1 (en) Composition for use in the prevention and / or treatment of gastric or gastroesophageal disorders.
SG11202102412UA (en) Semiconductor aqueous composition and use of the same
ITUA20163037A1 (en) Formulations for use in the treatment or prevention of urological disorders
EP3668836A4 (en) Compositions for the treatment of dry eye and methods of use thereof